Brain stress systems in the amygdala and addiction

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

A Syndrome produced by Diverse Nocuous Agents

Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967 · see citing works

Drug Addiction, Dysregulation of Reward, and Allostasis

Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953 · see citing works

Drug abuse: hedonic homeostatic dysregulation

Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · see citing works

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · see citing works

The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress

Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948 · see citing works

The reinstatement model of drug relapse: history, methodology and major findings

Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615 · see citing works

Addiction and the brain antireward system

Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457 · see citing works

Allostasis: A New Paradigm to Explain Arousal Pathology

Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450 · see citing works

Handbook of Life Stress, Cognition and Health

PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,402 · see citing works

CRF and CRF receptors: role in stress responsivity and other behaviors

Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270 · see citing works

New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata

Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217 · see citing works

A Role for Brain Stress Systems in Addiction

Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · see citing works

Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction

Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963 · see citing works

A Syndrome Produced by Diverse Nocuous Agents

Selye, H. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.2.230a · Cited by 925 · see citing works

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · see citing works

Urocortin II: A Member of the Corticotropin-Releasing Factor (CRF) Neuropeptide Family that Is Selectively Bound by Type 2 CRF Receptors

Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887 · see citing works

Further contributions to the study of the evolution of the forebrain

Johnston, J. B. (1923) · The Journal of Comparative Neurology · doi:10.1002/cne.900350502 · Cited by 667 · see citing works

Corticotropin-releasing factor, norepinephrine, and stress

Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · see citing works

Handbook of Life Stress, Cognition and Health

Fisher, S., & REASON, J. T. (1988) · Cited by 575 · see citing works

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · see citing works

A key role for corticotropin-releasing factor in alcohol dependence

Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 1× · see citing works

Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal

Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · see citing works

Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · see citing works

Neurobiological substrates for the dark side of compulsivity in addiction

Koob, G. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 458 · see citing works

Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors

WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430 · see citing works

Neurobiology of Addiction

(2006) · Neuroscience · doi:10.1016/s0306-4522(05)01473-9 · Cited by 427 · see citing works

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal

Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407 · see citing works

Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats

Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381 · see citing works

International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands

Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W., & Dautzenberg, F. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.3 · Cited by 365 · see citing works

Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms

Liu, X., & Weiss, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 359 · see citing works

CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat

Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353 · see citing works

Intrinsic GABAergic neurons in the rat central extended amygdala

Sun, N., & Cassell, M. D. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903300308 · Cited by 351 · see citing works

Excessive Ethanol Drinking Following a History of Dependence Animal Model of Allostasis

Roberts, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00167-0 · Cited by 349 · see citing works

Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol

Rimondini, R., Arlinde, C., Sommer, W. H., & Heilig, M. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 320 · see citing works

Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal

Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317 · see citing works

Amygdaloid Corticotropin‐Releasing Factor Targets Locus Coeruleus Dendrites: Substrate for the Co‐ordination of Emotional and Cognitive Limbs of the Stress Response

Van Bockstaele, E. J., Colago, E. E. O., & Valentino, R. J. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00254.x · Cited by 311 · see citing works

Piecing together the Puzzle of Basal Forebrain Anatomy

Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · cited 3× · see citing works

Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence

Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309 · see citing works

Increased GABA Release in the Central Amygdala of Ethanol-Dependent Rats

Roberto, M., Madamba, S. G., Stouffer, D. G., Parsons, L. H., & Siggins, G. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3004-04.2004 · Cited by 299 · see citing works

The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responsesa

Valentino, R. J., Foote, S. L., & Page, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49931.x · Cited by 292 · see citing works

Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats

Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276 · see citing works

Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors

Nie, Z., Schweitzer, P., Roberts, A. J., Madamba, S. G., Moore, S. D., & Siggins, G. R. (2004) · Science · doi:10.1126/science.1092550 · Cited by 267 · see citing works

Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats

Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255 · see citing works

A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence

Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F., Goldberg, G., Welch, B., & Mantero-atienza, E. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 248 · see citing works

Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor

Valentino, R. J., Page, M. E., & Curtis, A. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90855-p · Cited by 246 · see citing works

CRF–CRF ₁ system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats

George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · see citing works

Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression

Li, C., Vaughan, J. M., Sawchenko, P. E., & Vale, W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00991.2002 · Cited by 241 · see citing works

3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism

Gehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J. W., Song, M., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239 · see citing works

STRESS, AROUSAL, AND THE PITUITARY-ADRENAL SYSTEM: A PSYCHOENDOCRINE HYPOTHESIS

Hennessy, J. W., & Levine, S. (1979) · Cited by 238 · see citing works

Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake

Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237 · see citing works

The Stress Response: A New Perspective

Burchfield, S. R. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197912000-00008 · Cited by 233 · see citing works

Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226 · see citing works

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats

Basso, A. M., Spina, M. G., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190 · see citing works

High-priority communication I Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence

Valdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186 · see citing works

The basal forebrain : anatomy to function

Napier, T. C., Kalivas, P. W., & Hanin, I. (1991) · Plenum Press eBooks · Cited by 170 · see citing works

Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors

Overstreet, D. H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 169 · see citing works

α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol

Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 167 · see citing works

Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis

Kash, T. L., & Winder, D. G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.011 · Cited by 166 · see citing works

Neurobiology of addiction

Chou, I.-H., & Narasimhan, K. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1427 · Cited by 162 · see citing works

Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and results

Lowman, C., Allen, J., & Stout, R. L. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02327.x · Cited by 155 · see citing works

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats

Stinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139 · see citing works

Alcohol withdrawal symptoms and drinking behavior.

Hershon, H. I. (1977) · Journal of Studies on Alcohol · doi:10.15288/jsa.1977.38.953 · Cited by 139 · see citing works

α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access

Wee, S., Mandyam, C. D., Lekić, D., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.08.003 · Cited by 138 · see citing works

Noradrenaline Triggers GABAAInhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area

Dumont, É. C., & Williams, J. T. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0425-04.2004 · Cited by 137 · see citing works

Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus

Nestler, E. J., Alreja, M., & Aghajanian, G. K. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90166-x · Cited by 136 · see citing works

Increased Anxiety‐Like Behavior and Ethanol Self‐Administration in Dependent Rats: Reversal via Corticotropin‐Releasing Factor‐2 Receptor Activation

Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131 · see citing works

Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats

Alonso, G., SZAFARCZYK, A., Balmefrézol, M., & ASSENMACHER, I. (1986) · Brain Research · doi:10.1016/0006-8993(86)90631-1 · Cited by 130 · see citing works

SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats

Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130 · see citing works

Brain-Derived Neurotrophic Factor Is Essential for Opiate-Induced Plasticity of Noradrenergic Neurons

Akbarian, S., Rios, M., Liu, R.-J., Gold, S. J., Fong, H., Zeiler, S., Coppola, V., Tessarollo, L., Jones, K. R., Nestler, E. J., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-04153.2002 · Cited by 129 · see citing works

CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats

Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 129 · see citing works

Modifications in the response to alcohol following the establishment of physical dependence

Branchey, M. H., Rauscher, G., & Kissin, B. (1971) · Psychopharmacology · doi:10.1007/bf00406870 · Cited by 126 · see citing works

Alcohol Withdrawal Syndromes: Clinical Management with Lofexidine

Cushman, P., Forbes, R., Lemer, W., & Stewart, M. (1985) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1985.tb05527.x · Cited by 125 · see citing works

Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist

Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124 · see citing works

Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt’s relapse taxonomy

ZYWIAK, W. H., CONNORS, G. J., MAISTO, S. A., & WESTERBERG, V. S. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02332.x · Cited by 121 · see citing works

Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures

Becker, H. C. (1994) · Psychopharmacology · doi:10.1007/bf02244867 · Cited by 120 · see citing works

β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats

Harris, G. C., & Aston‐Jones, G. (1993) · Psychopharmacology · doi:10.1007/bf02244345 · Cited by 118 · see citing works

Brain arousal and information theory: neural and genetic mechanisms

(2006) · Choice Reviews Online · doi:10.5860/choice.43-5280 · Cited by 116 · see citing works

Hyperventilation, anxiety, craving for alcohol: A subacute alcohol withdrawal syndrome

Roelofs, S. M. G. J. (1985) · Alcohol · doi:10.1016/0741-8329(85)90123-5 · Cited by 116 · see citing works

Central Norepinephrine Metabolism During Alcohol Intoxication in Addicts and Healthy Volunteers

Borg, S., Kvande, H., & Sedvall, G. (1981) · Science · doi:10.1126/science.7268421 · Cited by 113 · see citing works

Ethanol-Associated Behaviors of Mice Lacking Norepinephrine

Weinshenker, D., Rust, N. C., Miller, N. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03157.2000 · Cited by 99 · see citing works

MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist

RICHARDSON, H., ZHAO, Y., Fekete, É. M., FUNK, C., Wirsching, P., Janda, K. D., Zorrilla, E. P., & Koob, G. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.008 · Cited by 95 · see citing works

Allostatic view of motivation: implications for psychopathology.

Koob, G. F. (2004) · PubMed · Cited by 89 · see citing works

PRECLINICAL STUDY: Corticotropin‐releasing factor‐1 receptor antagonists decrease heroin self‐administration in long‐ but not short‐access rats

Greenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87 · see citing works

INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION

Rohrer, D. K., & Kobilka, B. K. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.351 · Cited by 76 · see citing works

Studies on duration of a late recovery period after chronic abuse of ethanol

Alling, C., Balldin, J., Bokström, K., Gottfries, C. G., Karlsson, I., & Långström, G. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb06720.x · Cited by 75 · see citing works

Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization

Sharp, B. M., & Matta, S. G. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391419 · Cited by 74 · see citing works

Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics

Annis, H. M., Sklar, S. M., & Moser, A. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00024-5 · Cited by 72 · see citing works

The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats

Brown, Z. W., & Amit, Z. (1977) · Neuroscience Letters · doi:10.1016/0304-3940(77)90109-4 · Cited by 69 · see citing works

The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration

Greenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.012 · Cited by 69 · see citing works

Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.

Amit, Z., Zw, B., Levitan, D. E., & Ögren, S. O. (1977) · PubMed · Cited by 68 · see citing works

Norepinephrine Secretion in the Hypothalamic Paraventricular Nucleus of Rats during Unlimited Access to Self-Administered Nicotine: An<i>In Vivo</i>Microdialysis Study

Fu, Y., Matta, S. G., Brower, V. G., & Sharp, B. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08979.2001 · Cited by 66 · see citing works

Motivational factors in the etiology of drug abuse

Bevins, R. A., Bardo, M. T., & Koob, G. F. (2004) · Cited by 65 · see citing works

Potentiation of ethanol withdrawal by prior dependence

Baker, T. B., & Cannon, D. S. (1979) · Psychopharmacology · doi:10.1007/bf00432279 · Cited by 64 · see citing works

Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior

Slawecki, C. J., Thorsell, A. K., Khoury, A. E., Mathé, A. A., & Ehlers, C. L. (2005) · Neuropeptides · doi:10.1016/j.npep.2005.06.002 · Cited by 64 · see citing works

Clinical Conditions and Concentrations of MOPEG in the Cerebrospinal Fluid and Urine of Male Alcoholic Patients during Withdrawal

Borg, S., Czarnecka, A., Kvande, H., Mossberg, D., & Sedvall, G. (1983) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1983.tb05496.x · Cited by 46 · see citing works

Distribution of corticotropin-releasing factor-like immunoreactivity in human brain

Charlton, B. G., Ferrier, I. N., & Perry, R. H. (1987) · Neuropeptides · doi:10.1016/s0143-4179(87)90083-7 · Cited by 44 · see citing works

Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.

Fujimoto, A., Nagao, T., Ebara, T., Sato, M., & Otsuki, S. (1983) · PubMed · Cited by 40 · see citing works

PRECLINICAL STUDY: Long‐lasting tolerance to alcohol following a history of dependence

Rimondini, R., Sommer, W. H., Dall’Olio, R., & Heilig, M. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00079.x · Cited by 39 · see citing works

Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety

Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38 · see citing works

Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats

Schulteis, G. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00036-0 · Cited by 37 · see citing works

Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study

Fu, Y. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00201-6 · Cited by 36 · see citing works

Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal

Akbarian, S., Bates, B., Liu, R.-J., Skirboll, S. L., Pejchal, T., Coppola, V., Sun, L. D., Fan, G., Kučera, J., Wilson, M. A., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000897 · Cited by 36 · see citing works

Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain

Matta, S. G., Valentine, J. D., & Sharp, B. M. (1997) · Endocrine · doi:10.1007/bf02778147 · Cited by 34 · see citing works

Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex

Ventura, R., Carolis, D. D., Alcaro, A., & Puglisi‐Allegra, S. (2006) · Neuroreport · doi:10.1097/01.wnr.0000239964.83566.75 · Cited by 33 · see citing works

Reinforcement with intragastric infusions of ethanol: Blocking effect of FLA 57

Davis, W. M., Werner, T. E., & Smith, S. G. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90038-8 · Cited by 31 · see citing works

Noradrenaline and ethanol intake in the rat

Mason, S. T., Corcoran, M. E., & Fibiger, H. C. (1979) · Neuroscience Letters · doi:10.1016/0304-3940(79)91494-0 · Cited by 28 · see citing works

Ethanol-induced locomotor stimulation in C57BL/6 mice following RO15-4513 administration

Becker, H. C., & Hale, R. L. (1989) · Psychopharmacology · doi:10.1007/bf00445553 · Cited by 24 · see citing works

The roles of urocortins 1, 2, and 3 in the brain

Zorrilla, E. P., & Koob, G. F. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80013-6 · Cited by 11 · see citing works

Differences in uniquantal amplitude between sites reduce uniquantal variance when few release sites are active

Frerking, M., & Wilson, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4 · Cited by 2 · see citing works

Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: Evidence for their selective activation by interleukin-1?

Day, H. E. W., Curran, E. J., Watson, S. J., & Akil, H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991011)413:1

Neurocircuitry of Addiction

Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340 · see citing works

Rethinking the Emotional Brain

LeDoux, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.004 · Cited by 1,594 · see citing works

Amygdala circuitry mediating reversible and bidirectional control of anxiety

Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289 · see citing works

Stress-induced obesity and the emotional nervous system

Dallman, M. F. (2010) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2009.10.004 · Cited by 814 · see citing works

Impulsivity, frontal lobes and risk for addiction

Crews, F. T., & Boettiger, C. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.018 · Cited by 679 · see citing works

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503 · see citing works

Dynorphin, stress, and depression

Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465 · see citing works

Addiction and Brain Reward and Antireward Pathways

Gardner, E. L. (2011) · Advances in psychosomatic medicine · doi:10.1159/000324065 · Cited by 419 · see citing works

Sex differences in stress-related alcohol use

Peltier, M. R., Verplaetse, T. L., Mineur, Y. S., Petrakis, I. L., Cosgrove, K., Picciotto, M. R., & McKee, S. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100149 · Cited by 416 · see citing works

The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse

Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398 · see citing works

Alterations in brain structure and functional connectivity in prescription opioid-dependent patients

Upadhyay, J., Maleki, N., Potter, J. S., Elman, I., Rudrauf, D., Knudsen, J., Wallin, D. J., Pendse, G., McDonald, L., Griffin, M. L., et al. (2010) · Brain · doi:10.1093/brain/awq138 · Cited by 394 · see citing works

Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development

Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337 · see citing works

The human BNST: functional role in anxiety and addiction

Avery, S. N., Clauss, J. A., & Blackford, J. U. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.185 · Cited by 331 · see citing works

Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis

Becker, J. B., Perry, A. N., & Westenbroek, C. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-14 · Cited by 315 · see citing works

Addiction and Stress: An Allostatic View

Koob, G. F., & Schulkin, J. (2019) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315 · see citing works

Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism

Amaro, H. D. L. A., Sánchez, M., Bautista, T. G., & Cox, R. J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108518 · Cited by 334 · see citing works

The role of CRF and CRF-related peptides in the dark side of addiction

Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.008 · Cited by 290 · see citing works

Psychosocial versus physiological stress — Meta-analyses on deactivations and activations of the neural correlates of stress reactions

Kogler, L., Müller, V. I., Chang, A., Eickhoff, S. B., Fox, P. T., Gur, R. C., & Derntl, B. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.06.059 · Cited by 282 · see citing works

The impact of sugar consumption on stress driven, emotional and addictive behaviors

Jacques, A., Chaaya, N., Beecher, K., Ali, S. A., Belmer, A., & Bartlett, S. (2019) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.021 · Cited by 271 · see citing works

The Emergence of a Circuit Model for Addiction

Lüscher, C. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-013920 · Cited by 255 · see citing works

Neighborhood matters: divergent patterns of stress-induced plasticity across the brain

Chattarji, S., Tomar, A., Suvrathan, A., Ghosh, S., & Rahman, M. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4115 · Cited by 248 · see citing works

Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal

Sharma, S., Fernandes, M. F., & Fulton, S. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.197 · Cited by 231 · see citing works

Long-term effects of parental divorce on mental health – A meta-analysis

Auersperg, F., Vlasak, T., Ponocny, I., & Barth, A. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.09.011 · Cited by 223 · see citing works

Amygdala, neuropeptides, and chronic pain-related affective behaviors

Neugebauer, V., Mazzitelli, M., Cragg, B., Ji, G., Navratilova, E., & Porreca, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108052 · Cited by 216 · see citing works

Functional heterogeneity in the bed nucleus of the stria terminalis

Gungor, N. Z., & Pare, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0856-16.2016 · Cited by 214 · see citing works

Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses

Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205 · see citing works

NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking

Pleil, K. E., Rinker, J. A., Lowery-Gionta, E. G., Mazzone, C. M., McCall, N. M., Kendra, A. M., Olson, D. P., Lowell, B. B., Grant, K. A., Thiele, T. E., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3972 · Cited by 195 · see citing works

Affective valence in the brain: modules or modes?

Berridge, K. C. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0122-8 · Cited by 183 · see citing works

Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use

Preston, K. L., & Epstein, D. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2183-x · Cited by 171 · see citing works

Molecular mechanisms underlying alcohol-drinking behaviours

Ron, D., & Barak, S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.85 · Cited by 165 · see citing works

Caloric Restriction Experience Reprograms Stress and Orexigenic Pathways and Promotes Binge Eating

Pankevich, D. E., Teegarden, S. L., Hedin, A. D., Jensen, C. L., & Bale, T. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1955-10.2010 · Cited by 157 · see citing works

Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice

Lowery-Gionta, E. G., Navarro, M., Li, C., Pleil, K. E., Rinker, J. A., Cox, B. R., Sprow, G. M., Kash, T. L., & Thiele, T. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6256-11.2012 · Cited by 149 · see citing works

A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety

Pomrenze, M. B., Tovar-Díaz, J., Blasio, A., Maiya, R., Giovanetti, S. M., Lei, K., Morikawa, H., Hopf, F. W., & Messing, R. O. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2143-18.2018 · Cited by 134 · see citing works

Individual differences in the neuropsychopathology of addiction

George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 140 · see citing works

Stress regulates endocannabinoid-CB1 receptor signaling

Hillard, C. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.001 · Cited by 136 · see citing works

The Central Amygdala and Alcohol: Role of -Aminobutyric Acid, Glutamate, and NeuropeptidesPreprint

Roberto, M., Gilpin, N. W., & Siggins, G. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012195 · Cited by 136 · see citing works

The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice

Zanos, P., Georgiou, P., Wright, S. R., Hourani, S. M., Kitchen, I., Winsky-Sommerer, R., & Bailey, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.285 · Cited by 133 · see citing works

Down-Regulation of Amygdala and Insula Functional Circuits by Varenicline and Nicotine in Abstinent Cigarette Smokers

Sutherland, M. T., Carroll, A. J., Salmeron, B. J., Ross, T. J., Hong, L. E., & Stein, E. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.035 · Cited by 131 · see citing works

Role of the bed nucleus of the stria terminalis in aversive learning and memoryPreprint

Goode, T. D., & Maren, S. (2017) · Learning & Memory · doi:10.1101/lm.044206.116 · Cited by 138 · see citing works

A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor Circuits

Pomrenze, M. B., Millan, E. Z., Hopf, F. W., Keiflin, R., Maiya, R., Blasio, A., Dadgar, J., Kharazia, V., de Guglielmo, G., Crawford, E. F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00487 · Cited by 127 · see citing works

Pituitary Adenylate Cyclase Activating Polypeptide in Stress-Related Disorders: Data Convergence from Animal and Human Studies

Hammack, S. E., & May, V. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.003 · Cited by 127 · see citing works

Compulsive features in behavioural addictions: the case of pathological gambling

el‐Guebaly, N., Mudry, T., Zohar, J., Tavares, H., & Potenza, M. N. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03546.x · Cited by 130 · see citing works

Facets of impulsivity and alcohol use: What role do emotions play?

Herman, A. M., & Duka, T. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.011 · Cited by 131 · see citing works

Acute Effects of Heroin on Negative Emotional Processing: Relation of Amygdala Activity and Stress-Related Responses

Schmidt, A., Borgwardt, S., Gerber, H., Wiesbeck, G. A., Schmid, O., Riecher‐Rössler, A., Smieskova, R., Lang, U. E., & Walter, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.019 · Cited by 126 · see citing works

Responses of Glial Cells to Stress and Glucocorticoids

Jáuregui-Huerta, F., Ruvalcaba-Delgadillo, Y., González-Pérez, Ó., González-Castañeda, R. E., Garcı́a‐Estrada, J., & Luquı́n, S. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823790 · Cited by 127 · see citing works

Effects of Alcohol on the Endocrine System

Rachdaoui, N., & Sarkar, D. K. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.008 · Cited by 128 · see citing works

Noradrenergic targets for the treatment of alcohol use disorder

Haass-Koffler, C. L., Swift, R. M., & Leggio, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4843-6 · Cited by 117 · see citing works

Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse

Frank, M. G., Watkins, L. R., & Maier, S. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.01.005 · Cited by 116 · see citing works

The role of stress in drug addiction. An integrative review

Ruisoto, P., & Contador, I. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.01.022 · Cited by 119 · see citing works

Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats

Anker, J. J., & Carroll, M. E. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1721-2 · Cited by 115 · see citing works

Morphine‐enhanced apoptosis in selective brain regions of neonatal rats

Bajic, D., Commons, K. G., & Soriano, S. G. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.009 · Cited by 111 · see citing works

Animal models of post-traumatic stress disorder and recent neurobiological insights

Whitaker, A. M., Gilpin, N. W., & Edwards, S. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000069 · Cited by 110 · see citing works

CRF-Amplified Neuronal TLR4/MCP-1 Signaling Regulates Alcohol Self-Administration

June, H. L., Liu, J., Warnock, K. T., Bell, K., Balan, I. S., Bollino, D. R., Puché, A. C., & Aurelian, L. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.4 · Cited by 108 · see citing works

Recruitment of a neuronal ensemble in the central nucleus of the amygdala is required for alcohol dependence

de Guglielmo, G., Crawford, E., Kim, S., Vendruscolo, L. F., Hope, B. T., Brennan, M., Cole, M., Koob, G. F., & George, O. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1395-16.2016 · Cited by 106 · see citing works

Inhibition of Lactate Transport Erases Drug Memory and Prevents Drug Relapse

Zhang, Y., Xue, Y., Meng, S., Luo, Y., Liang, J., Li, J., Ai, S., Sun, C., Shen, H., Zhu, W., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.007 · Cited by 106 · see citing works

Stress modulates illness-course of substance use disorders: a translational review

Lijffijt, M., Hu, K., & Swann, A. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00083 · Cited by 103 · see citing works

Stress-Induced Activation of the Dynorphin/κ-Opioid Receptor System in the Amygdala Potentiates Nicotine Conditioned Place Preference

Smith, J. S., Schindler, A. G., Martinelli, E., Gustin, R. M., Bruchas, M. R., & Chavkin, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2980-11.2012 · Cited by 102 · see citing works

Psychedelic therapy in the treatment of addiction: the past, present and future

Zafar, R. R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., Roseman, L., Wall, M. B., Nutt, D., & Erritzøe, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183740 · Cited by 108 · see citing works

Psilocybin for treating substance use disorders?

de Veen, B. T. H., Schellekens, A., Verheij, M. M. M., & Homberg, J. R. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1220834 · Cited by 99 · see citing works

COVID-19 and Substance Use Disorders as Brain Diseases: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

Farhoudian, A., Baldacchino, A., Clark, N. C., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., et al. (2020) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.11.covid19.1 · Cited by 102 · see citing works

Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder

Norman, S. B., Myers, U. S., Wilkins, K. C., Goldsmith, A. A., Hristova, V., Huang, Z., McCullough, K. C., & Robinson, S. K. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.032 · Cited by 95 · see citing works

A Pilot Trial of Prazosin, an Alpha‐1 Adrenergic Antagonist, for Comorbid Alcohol Dependence and Posttraumatic Stress Disorder

Simpson, T. L., Malte, C. A., Dietel, B., Tell, D., Pocock, I., Lyons, R. C., Varon, D., Raskind, M. A., & Saxon, A. J. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12703 · Cited by 95 · see citing works

Understanding neurobehavioral effects of acute and chronic stress in zebrafish

Demin, K. A., Taranov, A. S., Ilyin, N. P., Lakstygal, A. M., Volgin, A. D., de Abreu, M. S., Strekalova, T. V., & Kalueff, A. V. (2020) · Stress · doi:10.1080/10253890.2020.1724948 · Cited by 96 · see citing works

Emerging Role for Corticotropin Releasing Factor Signaling in the Bed Nucleus of the Stria Terminalis at the Intersection of Stress and Reward

Silberman, Y., & Winder, D. G. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00042 · Cited by 91 · see citing works

Signaling Pathways Mediating Alcohol Effects

Dorit Ron, A., & Messing, R. O. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_161 · Cited by 85 · see citing works

Harmonizing DTI measurements across scanners to examine the development of white matter microstructure in 803 adolescents of the NCANDA study

Pohl, K. M., Sullivan, E. V., Rohlfing, T., Chu, W., Kwon, D., Nichols, B. N., Zhang, Y., Brown, S. A., Tapert, S. F., Cummins, K., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.01.061 · Cited by 85 · see citing works

Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?

Brandt, L., Chao, T. W.-C., Comer, S. D., & LEVIN, F. R. (2020) · Addiction · doi:10.1111/add.15242 · Cited by 85 · see citing works

Sex, stress, and epigenetics: regulation of behavior in animal models of mood disorders

Hodes, G. E. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-1 · Cited by 82 · see citing works

Differential Effects of Single Versus Repeated Alcohol Withdrawal on the Expression of Endocannabinoid System‐Related Genes in the Rat Amygdala

Serrano, A., Rivera, P., Pavón, F. J., Decara, J. M., Suárez, J., de Fonseca, F. R., & Parsons, L. H. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01686.x · Cited by 83 · see citing works

Potential of zebrafish as a model for exploring the role of the amygdala in emotional memory and motivational behavior

Perathoner, S., Cordero-Maldonado, M. L., & Crawford, A. D. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23712 · Cited by 82 · see citing works

Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference

Landgren, S., Engel, J. A., Hyytiä, P., Zetterberg, H., Blennow, K., & Jerlhag, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.003 · Cited by 80 · see citing works

Neural pathways of stress integration: relevance to alcohol abuse

Herman, J. P. (2012) · Alcohol research · doi:10.35946/arcr.v34.4.08 · Cited by 77 · see citing works

Amygdala NRG1–ErbB4 Is Critical for the Modulation of Anxiety-Like Behaviors

Bi, L.-L., Sun, X.-D., Zhang, J., Lu, Y.-S., Chen, Y.-H., Wang, J., Geng, F., Liu, F., Zhang, M., Liu, J.-H., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.274 · Cited by 76 · see citing works

Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking

Cippitelli, A., Damadzic, R., Hansson, A. C., Singley, E., Sommer, W. H., Eskay, R. L., Thorsell, A., & Heilig, M. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1741-y · Cited by 76 · see citing works

Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder

Simpson, T. L., Saxon, A. J., Stappenbeck, C. A., Malte, C. A., Lyons, R. C., Tell, D., Millard, S. P., & Raskind, M. A. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17080913 · Cited by 76 · see citing works

Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study

Chye, Y., Mackey, S., Gutman, B. A., Ching, C. R. K., Batalla, A., Blaine, S. K., Brooks, S. J., Caparelli, E. C., Cousijn, J., Dagher, A., et al. (2019) · Addiction Biology · doi:10.1111/adb.12830 · Cited by 79 · see citing works

Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis

O’Sullivan, S. J., Malahias, E., Park, J., Srivastava, A., Reyes, B. A. S., Gorky, J., Vadigepalli, R., Bockstaele, E. J. V., & Schwaber, J. S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00665 · Cited by 71 · see citing works

Environmental living conditions introduced during forced abstinence alter cocaine-seeking behavior and Fos protein expression

Thiel, K. J., Pentkowski, N. S., Peartree, N. A., Painter, M. R., & Neisewander, J. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.001 · Cited by 75 · see citing works

Agonist Medications for the Treatment of Cocaine Use Disorder

Negus, S. S., & Henningfield, J. E. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.322 · Cited by 72 · see citing works

Traumatic brain injury induces neuroinflammation and neuronal degeneration that is associated with escalated alcohol self-administration in rats

Mayeux, J. P., Teng, S. X., Katz, P. S., Gilpin, N. W., & Molina, P. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.053 · Cited by 71 · see citing works

The cue-reactivity paradigm: An ensemble of networks driving attention and cognition when viewing drug and natural reward-related stimuli

Hill-Bowen, L. D., Riedel, M. C., Poudel, R., Salo, T., Flannery, J. S., Camilleri, J. A., Eickhoff, S. B., Laird, A. R., & Sutherland, M. T. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.010 · Cited by 70 · see citing works

rTMS-Induced Changes in Glutamatergic and Dopaminergic Systems: Relevance to Cocaine and Methamphetamine Use Disorders

Moretti, J., Poh, E. Z., & Rodger, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00137 · Cited by 66 · see citing works

Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala

Silberman, Y., & Winder, D. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.014 · Cited by 67 · see citing works

The role of inflammatory cytokines and ERK1/2 signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders

Hu, C., Yang, H., Zhao, Y., Chen, X., Dong, Y., Li, L., Dong, Y., Cui, J., Zhu, T., Zheng, P., et al. (2016) · Scientific Reports · doi:10.1038/srep28608 · Cited by 65 · see citing works

Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction

Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 66 · see citing works

Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats

Kallupi, M., Carrette, L. L. G., Kononoff, J., Solberg Woods, L. C., Palmer, A. A., Schweitzer, P., George, O., & de Guglielmo, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915143117 · Cited by 64 · see citing works

Zebrafish models relevant to studying central opioid and endocannabinoid systems

Demin, K. A., Мешалкина, Д. А., Kysil, E. V., Antonova, K. A., Volgin, A. D., Yakovlev, O. A., Alekseeva, P. A., Firuleva, M. M., Lakstygal, A. M., de Abreu, M. S., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.024 · Cited by 64 · see citing works

Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala

Nygard, S. K., Hourguettes, N. J., Sobczak, G. G., Carlezon, W. A., & Bruchas, M. R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0953-16.2016 · Cited by 61 · see citing works

Depletion of the Microbiome Alters the Recruitment of Neuronal Ensembles of Oxycodone Intoxication and Withdrawal

Simpson, S., Kimbrough, A., Boomhower, B., Mclellan, R., Hughes, M., Shankar, K., de Guglielmo, G., & George, O. (2020) · eNeuro · doi:10.1523/eneuro.0312-19.2020 · Cited by 61 · see citing works

Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety

Knapp, D. J., Whitman, B. A., Wills, T. A., Angel, R. A., Overstreet, D. H., Criswell, H. E., Ming, Z., & Breese, G. R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.018 · Cited by 60 · see citing works

Transitionality in addiction: A “temporal continuum” hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning

Patrono, E., Gasbarri, A., Tomaz, C. A. B., & Nishijo, H. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.05.015 · Cited by 60 · see citing works

Noradrenergic Synaptic Function in the Bed Nucleus of the Stria Terminalis Varies in Animal Models of Anxiety and Addiction

McElligott, Z. A., Fox, M. E., Walsh, P. L., Urban, D. J., Ferrel, M. S., Roth, B. L., & Wightman, R. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.63 · Cited by 60 · see citing works

Opioid use disorder and the brain: a clinical perspective

Herlinger, K., & Lingford-Hughes, A. R. (2021) · Addiction · doi:10.1111/add.15636 · Cited by 60 · see citing works

Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network

Merrer, J. L., Befort, K., Gardon, O., Filliol, D., Darcq, E., Dembélé, D., Becker, J. A. J., & Kieffer, B. L. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00365.x · Cited by 58 · see citing works

Regulating Prefrontal Cortex Activation: An Emerging Role for the 5-HT2A Serotonin Receptor in the Modulation of Emotion-Based Actions?

Aznar, S., & Klein, A. B. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8472-0 · Cited by 58 · see citing works

CRF1 Receptor Signaling Regulates Food and Fluid Intake in the Drinking-in-the-Dark Model of Binge Alcohol Consumption

Giardino, W. J., & Ryabinin, A. E. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12076 · Cited by 58 · see citing works

Role of amygdala in drug memory

Luo, Y., Xue, Y.-X., Shen, H., & Lü, L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.06.017 · Cited by 55 · see citing works

Shared Neural Correlates Underlying Addictive Disorders and Negative Urgency

Um, M., Whitt, Z. T., Revilla, R., Hunton, T., & Cyders, M. A. (2019) · Brain Sciences · doi:10.3390/brainsci9020036 · Cited by 53 · see citing works

Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression

Anderson, S. A. R., Michaelides, M., Zarnegar, P., Ren, Y., Fagergren, P., Thanos, P. K., Wang, G., Bannon, M. J., Neumaier, J. F., Keller, É., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70395 · Cited by 53 · see citing works

Intersection of stress and gender in association with transitions in past year DSM-5 substance use disorder diagnoses in the United States

Verplaetse, T., Moore, K., Pittman, B., Roberts, W., Oberleitner, L. M. S., Smith, P. H., Cosgrove, K. P., & McKee, S. (2018) · Chronic Stress · doi:10.1177/2470547017752637 · Cited by 43 · see citing works

A Role for Brain Stress Systems in Addiction

Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · see citing works

The role of CRF and CRF-related peptides in the dark side of addiction

Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.008 · Cited by 290 · see citing works

Corticotropin releasing factor: A key role in the neurobiology of addiction

Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 255 · see citing works

Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin

Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., & Weiss, F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.027 · Cited by 112 · see citing works

Corticotropin-Releasing Factor (CRF) and Addictive Behaviors

Roberto, M., Spierling, S. R., Kirson, D., & Zorrilla, E. P. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.06.004 · Cited by 58 · see citing works